Loading clinical trials...
Loading clinical trials...
A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-Infected Ugandan Women
Conditions
Interventions
Etonogestrel
Locations
1
Uganda
Infectious Disease Institute
Kampala, Uganda
Start Date
October 1, 2014
Primary Completion Date
March 1, 2016
Completion Date
March 1, 2016
Last Updated
September 14, 2017
NCT04929028
NCT07071623
NCT01875588
NCT03087253
NCT07199335
NCT06345586
Lead Sponsor
University of Pittsburgh
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions